Search In this Thesis
   Search In this Thesis  
العنوان
PREVELANCE OF HEPATITIS (C) VIRUS ANTIBODIES AMONG HAEMODIALYSIS PATIENTS IN AL-QALYUBIA GOVERNERATE
SECTOR (B)
\
المؤلف
Shokr,Abdelsamad Elsayed Abdelsamad
هيئة الاعداد
باحث / عبدالصمد السيد عبدالصمد شكر
مشرف / هويدا عبدالحميد الشناوى
مشرف / وليد أنور عبدالمحسن
الموضوع
HEPATITIS (C) VIRUS ANTIBODIES AMONG HAEMODIALYSIS PATIENTS-
تاريخ النشر
2011
عدد الصفحات
193.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب الباطني
تاريخ الإجازة
1/1/2011
مكان الإجازة
جامعة عين شمس - كلية الطب - Internal Medicine
الفهرس
Only 14 pages are availabe for public view

from 37

from 37

Abstract

Infection with HCV is the most common liver disease in HD patients, while liver disease is a significant cause of morbidity in patients with end stage renal disease treated by dialysis or transplan¬tation.
Hepatitis C virus (HCV) prevalence differs among hemodialysis units according to their geographical location, health care procedures, socioeconomic factors, reuse of lines, hygiene and sterilization of equipment, patient rotation of machines and the undertaking of rigorous universal precaution rules. These features influence the risk of nosocomial transmission of HCV to hemodialysis patients.
The prevalence of hepatitis C virus (HCV) infection is estimated to be 2% worldwide, Egypt has the largest epidemic of hepatitis C virus (HCV) in the world with 14.7% of the population are infected with HCV.
The prevalence of anti-HCV positivity among dialysis patients varies in different countries (5%-85% worldwide), but may exceed 95% in some HD units.
This work is a part of project aiming at making survey about HCV, assessment its prevalence, its seroconversion and study risk factors associated with HCV seroconversion among all hemodialysis patients in Egypt. This project is modulated by Nephrology department, Ain Shams university.
All patients in the work were evaluated using questionnaire form for assessment of risk factors causing HCV infection in hemodialysis patients such as; Age, Sex, Duration of hemodialysis , Previous blood transfusion, Previous surgery, Isolation procedures in the centers, Dialysis in other centers, Vascular access used, History of Shistosomiasis, History of HBs Ag, Family history of hepatitis and Causes of chronic kidney disease.